Secondary prophylaxis of spontaneous bacterial peritonitis in patients with cirrhosis

For secondary prophylaxis of spontaneous bacterial peritonitis in adults and children with ascites due to cirrhosis, use:

trimethoprim+sulfamethoxazole 160+800 mg (child 1 month or older: 4+20 mg/kg up to 160+800 mg) orally, daily. For dosage adjustment in adults with kidney impairment, see trimethoprim+sulfamethoxazole dosage adjustment . trimethoprim + sulfamethoxazole trimethoprim+sulfamethoxazole trimethoprim+sulfamethoxazole

Although more published trials have used norfloxacin for the secondary prophylaxis of spontaneous bacterial peritonitis, trimethoprim+sulfamethoxazole is preferred to minimise emergence of resistance to quinolones (both in the individual and the wider community)Alvarez, 2005Lontos, 2014Singh, 1995. However, norfloxacin is preferred for secondary prophylaxis of spontaneous bacterial peritonitis in patients:

  • who have an episode of spontaneous bacterial peritonitis while taking trimethoprim+sulfamethoxazole for secondary prophylaxis
  • with hypersensitivity to trimethoprim+sulfamethoxazole (assess patients reporting hypersensitivity to trimethoprim+sulfamethoxazole – for adults, see here or for children, seek expert advice)
  • in whom a trimethoprim+sulfamethoxazole-resistant organism is cultured from a previous episode of spontaneous bacterial peritonitis.

If norfloxacin is preferred for secondary prophylaxis of spontaneous bacterial peritonitis, use:

norfloxacin 400 mg (child: 10 mg/kg up to 400 mg) orally, daily12. For dosage adjustment in adults with kidney impairment, see norfloxacin dosage adjustment. norfloxacin norfloxacin norfloxacin

Multiple studies have examined other antibiotic prophylaxis options (eg rifaximin, ciprofloxacin); however, there is not enough high-quality evidence to recommend their useKomolafe, 2020.

1 Norfloxacin is not licensed for use in children on the basis of animal studies that showed an adverse effect on cartilage development with quinolone use; however, clinical trial data suggest that adverse musculoskeletal events are usually mild and short term, similar to those observed in adults. Norfloxacin can be used in children when it is the drug of choice.Return
2 An oral liquid formulation of norfloxacin is not commercially available; for formulation options for children or people with swallowing difficulties, see Don’t Rush to Crush, which is available for purchase from the Advanced Pharmacy Australia website or through a subscription to eMIMSplus.Return